{{Rsnum
|rsid=3796619
|Gene=RNF212
|Chromosome=4
|position=1101493
|Orientation=minus
|GMAF=0.4568
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=RNF212
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 45.1 | 43.4 | 11.5
| HCB | 46.0 | 42.3 | 11.7
| JPT | 23.9 | 58.4 | 17.7
| YRI | 4.8 | 29.9 | 65.3
| ASW | 10.5 | 45.6 | 43.9
| CHB | 46.0 | 42.3 | 11.7
| CHD | 40.4 | 44.0 | 15.6
| GIH | 40.6 | 45.5 | 13.9
| LWK | 1.8 | 34.5 | 63.6
| MEX | 41.4 | 31.0 | 27.6
| MKK | 11.5 | 36.5 | 51.9
| TSI | 37.3 | 45.1 | 17.6
| HapMapRevision=28
}}{{GWAS Summary
|SNP=rs3796619
|PubMedID=18239089
|Condition=Recombination rate (males)
|Gene=RNF212,SPON2
|Risk Allele=T
|pValue=3.00E-024
|OR=70.7
|95CI=84.3-57.1) cM decreas
}}

{{omim
|desc=RECOMBINATION RATE QUANTITATIVE TRAIT LOCUS 1; RRQTL1
|id=612042
|rsnum=3796619
}}

{{omim
|id=612041
|desc=RING FINGER PROTEIN 212; RNF212
|rsnum=3796619
}}

{{PharmGKB
|RSID=rs3796619
|Name_s=
|Gene_s=RNF212
|Feature=
|Evidence=PubMed ID:18239089; Web Resource:http://www.genome.gov/gwastudies/
|Annotation=GWAS Results: Sequence Variants in the RNF212 Gene Associate with Genomewide Recombination Rate (Initial Sample Size: 1,887 men; Replication Sample Size: 1,248 men; Risk Allele: rs3796619-T).
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Non-Curated
|PharmGKB Accession ID=PA162356737
}}

{{PharmGKB
|RSID=rs3796619
|Name_s=
|Gene_s=RNF212
|Feature=
|Evidence=PubMed ID:18239089
|Annotation=This SNP is correlated with genome-wide recombination rate;opposite effects are observed in males and females.
|Drugs=
|Drug Classes=
|Diseases=
|Curation Level=Curated
|PharmGKB Accession ID=PA161422481
}}

{{omim
|id=612041
|rsnum=3796619
|variant=0001
}}

{{PMID Auto
|PMID=19002143
|Title=Sex-specific genetic architecture of human disease.
|OA=1
}}

{{PMID Auto
|PMID=19763160
|Title=Genetic analysis of variation in human meiotic recombination.
|OA=1
}}

{{PMID Auto
|PMID=20369022
|Title=Candidate causal regulatory effects by integration of expression QTLs with complex trait genetic associations.
|OA=1
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs3796619
|overall_frequency_n=69
|overall_frequency_d=128
|overall_frequency=0.539062
|n_genomes=39
|n_genomes_annotated=0
|n_haplomes=55
|n_articles=1
|n_articles_annotated=0
|in_gwas=Y
|in_pharmgkb=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}